Peer-reviewedCC BYFrontiers in neurology
Real-world effectiveness and safety of lasmiditan in patients with migraine: an observational study
- 1Department of Neurology, Dokkyo Medical University , ,
Related
- Effectiveness and safety of lasmiditan and rimegepant in the acute migraine treatment: an indirect real-world comparison
- Real-world effectiveness and safety of enavogliflozin in patients with type 2 diabetes: A 24-week prospective multicenter observational study in Korea.
- Effectiveness and safety of imeglimin in routine clinical practice among Indian patients with type 2 diabetes mellitus: a prospective, non-interventional, real-world observational study (INDI-TIMES 2.0)
- Effectiveness, safety and persistence of filgotinib in rheumatoid arthritis with a specific focus on difficult-to-treat patients: results from a multicentre observational study.
- Effectiveness and safety of Janus Kinase inhibitors in patients with rheumatoid arthritis, results from a multicenter observational “real-life” GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study
BibTeX
@article{kobayashi2026realworld,
title = {{Real-world effectiveness and safety of lasmiditan in patients with migraine: an observational study}},
author = {Saro Kobayashi and Shiho Suzuki and Mukuto Shioda and Tomohiko Shiina and Hiroaki Fujita and Hirotaka Sakuramoto and Ryotaro Hida and Keisuke Suzuki},
journal = {Frontiers in neurology},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13657970},
note = {CC BY},
}
RIS
TY - JOUR
TI - Real-world effectiveness and safety of lasmiditan in patients with migraine: an observational study
AU - Saro Kobayashi
AU - Shiho Suzuki
AU - Mukuto Shioda
AU - Tomohiko Shiina
AU - Hiroaki Fujita
AU - Hirotaka Sakuramoto
AU - Ryotaro Hida
AU - Keisuke Suzuki
PY - 2026
DA - 2026/10/16
JO - Frontiers in neurology
UR - https://europepmc.org/article/PMC/PMC13657970
SN - 1664-2295
ER -